CTRI/2024/07/071305尚未招募Unknown
Correlation of CA19-9 levels and resectability of pancreatic tumours - NI
Dr Shrey Khanna0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Phase 1 -All patients diagnosed with pancreatic cancer above 18 years of age
- •Phase 2 -All Patients consenting to the study who are-
- •Patients newly diagnosed with pancreatic tumour based on CT/MRI Findings or Biopsy
- •Patients who are known case of pancreatic tumour presenting to the hospital for further management
排除标准
- •Patients under 18 years of age
- •Neuroendocrine tumours of the pancreas
研究者
相似试验
尚未招募
不适用
Clinical Value of CA 19-9 with Reference to the Lewis Blood Group Status for Prediction of Benign and Malignant Obstructive JaundiceObstructive jaundiceCA 19NjLewis blood groupTCTR20160927002The Thailand Research Fund (TRF)129
已完成
不适用
To find a tumor marker in colorectal cancer where the conventional marker fails and its impact on short term patient survivalCTRI/2021/09/036543Medical College Kolkata41
已完成
不适用
Carbohydrate antigen19-9 (CA19-9) levels in patients with autosomal dominant polycystic kidney disease (ADPKD)autosomal dominant polycystic kidney diseaseJPRN-UMIN000021735Iwata City Hospital200
已完成
Unknown
Proposed cut-off CA19-9 values for detection of pancreatic cancer in patients with poorly glycemic controlled diabetes: a real-world studydiabetes mellitus, pancreatic cancerJPRN-UMIN000049985Saiseikai Yokohamashi Nanbu Hospital1,060
已完成
不适用
The influence of CYP2C19 loss-of-function alleles on atherothrombotic events in patients on clopidogrel after endovascular aneurysm repair (EVAR)NL-OMON55153Radboud Universitair Medisch Centrum300